Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
|
|
Chelsea Therapeutics International, Ltd. (CHTP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/21/2013 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/17/2013 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/04/2013 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/19/2012 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 07/06/2012 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 03/11/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 01/11/2010 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 10/27/2009 |
SC 13D/A
| Chelsea Therapeutics International, Ltd. reports a 24% stake in CHELSEA THERAPEUTICS INTERNATIONAL, LTD. |
| 09/29/2009 |
SC 13D/A
| Chelsea Therapeutics International, Ltd. reports a 0% stake in Chelsea Therapeutics International, Ltd. |
| 02/27/2009 |
SC 13D/A
| Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend] |
| 09/19/2008 |
SC 13D/A
| MILLENNIUM PARTNERS, L.P. reports a 7.1% stake in Chelsea Therapeutics International, Ltd. |
| 08/02/2007 |
SC 13D/A
| AUSTIN JOSIAH T reports a 20.1% stake in CHELSEA THERAPEUTICS INTERNATIONAL, LTD. |
| 07/24/2007 |
SC 13D/A
| AUSTIN JOSIAH T reports a 19.7% stake in CHELSEA THERAPEUTICS INTERNATIONAL, LTD. |
| 07/09/2007 |
SC 13D/A
| AUSTIN JOSIAH T reports a 18% stake in CHELSEA THERAPEUTICS INTERNATIONAL, LTD. |
| 05/29/2007 |
SC 13D/A
| AUSTIN JOSIAH T reports a 14.9% stake in CHELSEA THERAPEUTICS INTERNATIONAL, LTD. |
| 04/03/2007 |
SC 13D/A
| AUSTIN JOSIAH T reports a 13.5% stake in Chelsea Therapeutics International, Ltd. |
|
|